Regulative characteristics of β-adrenoreceptor subtypal function in patients with essential hypertension by chronic β1-selective antagonist

P. Yingxin, M. Shuping, Yulong Li

Research output: Contribution to journalArticle

Abstract

Objective To study the effect of chronic β1-selective blockor treatment on β-adrenoreceptor subtypal function in human. Methods Cardiac β1-adrenoreceptor subtypes responsiveness were measured by treadmill exercise test and cardiac β2-adrenoreceptor responsiveness by salbutamol injection test in 20 male patients with essential hypertension (EH) after β1-selective blockor treatment for at least 4 months and withdrawal for 3 days. The twenty male patients with EH and non-β-blockors treatment for at least 4 months were used as controls. Results The increases in peak exercise heart rate by treadmill were not significantly different between the patients with β1-blockor treatment and those with non-β-blockor treatment. The chronotropic dose of salbutamol that increased heart rate by 30 beats/min [chronotropic dose 30 (CD30)] in [β1-blockor treatment group were significantly lower than those in non-β-blockor treatment group (1.8 ± 0.3 vs 2.7 ± 0.2 μg/kg, P < 0.001). Blood pressures did not change significantly after salbutamol injection in both groups. Conclusion The treatment with β1-selective blockor leads to cross sensitisation of cardiac β2-adrenoreceptor in human. This is the possible celluological mechanism of the β-blockor withdrawal syndrome.

Original languageEnglish (US)
Pages (from-to)337-339
Number of pages3
JournalChinese Journal of Cardiology
Volume26
Issue number5
StatePublished - Dec 1 1998
Externally publishedYes

Fingerprint

Albuterol
Therapeutics
Exercise Test
Heart Rate
Injections
Essential Hypertension
Exercise
Blood Pressure

Keywords

  • Adrenergic
  • Adrenergic beta-antagonists
  • Beta-1
  • Hypertension receptors

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Regulative characteristics of β-adrenoreceptor subtypal function in patients with essential hypertension by chronic β1-selective antagonist. / Yingxin, P.; Shuping, M.; Li, Yulong.

In: Chinese Journal of Cardiology, Vol. 26, No. 5, 01.12.1998, p. 337-339.

Research output: Contribution to journalArticle

@article{bb576d2e5a50472d9457a761bd8fd590,
title = "Regulative characteristics of β-adrenoreceptor subtypal function in patients with essential hypertension by chronic β1-selective antagonist",
abstract = "Objective To study the effect of chronic β1-selective blockor treatment on β-adrenoreceptor subtypal function in human. Methods Cardiac β1-adrenoreceptor subtypes responsiveness were measured by treadmill exercise test and cardiac β2-adrenoreceptor responsiveness by salbutamol injection test in 20 male patients with essential hypertension (EH) after β1-selective blockor treatment for at least 4 months and withdrawal for 3 days. The twenty male patients with EH and non-β-blockors treatment for at least 4 months were used as controls. Results The increases in peak exercise heart rate by treadmill were not significantly different between the patients with β1-blockor treatment and those with non-β-blockor treatment. The chronotropic dose of salbutamol that increased heart rate by 30 beats/min [chronotropic dose 30 (CD30)] in [β1-blockor treatment group were significantly lower than those in non-β-blockor treatment group (1.8 ± 0.3 vs 2.7 ± 0.2 μg/kg, P < 0.001). Blood pressures did not change significantly after salbutamol injection in both groups. Conclusion The treatment with β1-selective blockor leads to cross sensitisation of cardiac β2-adrenoreceptor in human. This is the possible celluological mechanism of the β-blockor withdrawal syndrome.",
keywords = "Adrenergic, Adrenergic beta-antagonists, Beta-1, Hypertension receptors",
author = "P. Yingxin and M. Shuping and Yulong Li",
year = "1998",
month = "12",
day = "1",
language = "English (US)",
volume = "26",
pages = "337--339",
journal = "Chinese Journal of Cardiology",
issn = "0253-3758",
publisher = "Chinese Medical Association",
number = "5",

}

TY - JOUR

T1 - Regulative characteristics of β-adrenoreceptor subtypal function in patients with essential hypertension by chronic β1-selective antagonist

AU - Yingxin, P.

AU - Shuping, M.

AU - Li, Yulong

PY - 1998/12/1

Y1 - 1998/12/1

N2 - Objective To study the effect of chronic β1-selective blockor treatment on β-adrenoreceptor subtypal function in human. Methods Cardiac β1-adrenoreceptor subtypes responsiveness were measured by treadmill exercise test and cardiac β2-adrenoreceptor responsiveness by salbutamol injection test in 20 male patients with essential hypertension (EH) after β1-selective blockor treatment for at least 4 months and withdrawal for 3 days. The twenty male patients with EH and non-β-blockors treatment for at least 4 months were used as controls. Results The increases in peak exercise heart rate by treadmill were not significantly different between the patients with β1-blockor treatment and those with non-β-blockor treatment. The chronotropic dose of salbutamol that increased heart rate by 30 beats/min [chronotropic dose 30 (CD30)] in [β1-blockor treatment group were significantly lower than those in non-β-blockor treatment group (1.8 ± 0.3 vs 2.7 ± 0.2 μg/kg, P < 0.001). Blood pressures did not change significantly after salbutamol injection in both groups. Conclusion The treatment with β1-selective blockor leads to cross sensitisation of cardiac β2-adrenoreceptor in human. This is the possible celluological mechanism of the β-blockor withdrawal syndrome.

AB - Objective To study the effect of chronic β1-selective blockor treatment on β-adrenoreceptor subtypal function in human. Methods Cardiac β1-adrenoreceptor subtypes responsiveness were measured by treadmill exercise test and cardiac β2-adrenoreceptor responsiveness by salbutamol injection test in 20 male patients with essential hypertension (EH) after β1-selective blockor treatment for at least 4 months and withdrawal for 3 days. The twenty male patients with EH and non-β-blockors treatment for at least 4 months were used as controls. Results The increases in peak exercise heart rate by treadmill were not significantly different between the patients with β1-blockor treatment and those with non-β-blockor treatment. The chronotropic dose of salbutamol that increased heart rate by 30 beats/min [chronotropic dose 30 (CD30)] in [β1-blockor treatment group were significantly lower than those in non-β-blockor treatment group (1.8 ± 0.3 vs 2.7 ± 0.2 μg/kg, P < 0.001). Blood pressures did not change significantly after salbutamol injection in both groups. Conclusion The treatment with β1-selective blockor leads to cross sensitisation of cardiac β2-adrenoreceptor in human. This is the possible celluological mechanism of the β-blockor withdrawal syndrome.

KW - Adrenergic

KW - Adrenergic beta-antagonists

KW - Beta-1

KW - Hypertension receptors

UR - http://www.scopus.com/inward/record.url?scp=0032419071&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032419071&partnerID=8YFLogxK

M3 - Article

VL - 26

SP - 337

EP - 339

JO - Chinese Journal of Cardiology

JF - Chinese Journal of Cardiology

SN - 0253-3758

IS - 5

ER -